ArticleJCI insight2026

Combined BET bromodomain and DNA methyltransferase inhibition targets critical survival pathways in transdifferentiated prostate cancer.

William K Storck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.